Alternatives to eMI Aesthetics

Embody advertises low promotional prices, but its legal schedules list different Start and Flat rates. Confirm the complete plan cost before paying; cancellation requires 72 hours’ notice before billing and unused bundle months generally are not refundable.

A sublingual (under-the-tongue), not injectable, GLP-1 program — $189/mo semaglutide and $319/mo tirzepatide on a 6-month prepay plan, $209/mo and $359/mo on a shorter 2-month plan — serving 34 states plus DC.

Cost this at the dose you will end up on, not the one you start at. Tirzepatide runs $280 per four weeks at 2.5 mg and $525 at 15 mg — thirteen cycles a year, so $3,640 against $6,825. Semaglutide is stranger: two of its five levels cover five weeks rather than four, which makes level three cheaper per week than level two despite the higher dose, and contradicts the sentence directly above the table.

Names four specific 503A compounding pharmacy partners directly — from $150/mo semaglutide, $241/mo tirzepatide on a 6-month plan, available as injection, drops, or pills — though state coverage isn't published.

The billing cycle is stated in the same sentence as the price, so the year is countable without guesswork: thirteen charges of $149 is $1,937 for semaglutide and $2,587 for tirzepatide. Both are founding rates the site says will rise to $179 and $249 — $2,327 and $3,237 a year. What you cannot read is any of its legal documents, because they are the homepage with a different title on the tab.

The sum is transparent and it is the seller's own: $99 a month for the service, plus the manufacturer's charge — $299 for the Zepbound starter pen, $149 for the Wegovy pill — giving $398 and $248. The first month is $25 instead of $99. Both of those manufacturer figures are LillyDirect's and NovoCare's own, so the arithmetic can be checked from outside, and it holds. What is not published is the ladder as your dose climbs.

Not a telehealth clinic at all — zero intake, zero video visit, because it's a manufacturer-direct pharmacy for Foundayo (orforglipron), priced on a four-tier dose ladder from $149/mo (0.8mg) through $199/mo (2.5mg) and $299/mo (5.5mg and 9mg) to $349/mo (14.5mg and 17.2mg) self-pay, that only fills a prescription your own doctor already wrote and sent to LillyDirect Pharmacy or a pharmacy of your choosing.

The cheapest sticker price reviewed — $100/mo semaglutide, $133/mo tirzepatide on the 3-month plans — but it requires a live video consult, names no pharmacy, and discloses no state list, which costs it on the exact factors that matter to a working mom's calendar.

A one-product shop — compounded tirzepatide microdosing only, $89 the first month then $199/mo all-in, no live video visit described anywhere in the flow, and unusually candid on-site that the trial evidence for microdosing specifically is thin — but there's no semaglutide option at all, and no individual physician, pharmacy, or state list named anywhere on the site checked.